{"nct_id":"NCT01797848","title":"Efficacy and Safety Evaluation of a Treatment Consisting of Peg Interferon Alfa + Ribavirin + Daclatasvir in HCV Genotype 1 and 4 Treatment naïve Patients","status":"WITHDRAWN","status_verified_date":"2013-11","start_date":"2014-06","start_date_type":null,"primary_completion_date":"2016-11","primary_completion_date_type":"ESTIMATED","completion_date":"2016-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}